Skip to content

InBody Validation Study

Validation of the InBody 770® for the Assessment of Body Composition

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02635958
Acronym
InBody
Enrollment
176
Registered
2015-12-21
Start date
2015-12-31
Completion date
2019-12-31
Last updated
2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Validation Study

Keywords

Body Mass Index, BMI, InBody, iDXA, validation

Brief summary

With, one in three Americans now having a body mass index (BMI) greater than 30, and the fastest growing segment of the population having a BMI greater than 40, it is paramount to conduct validation of approaches to measure body composition. Currently the dual-energy x-ray absorptiometry (iDXA) is the gold standard for measuring the body composition. But it is often difficult to perform since it is limited to specific height, weight and BMI's. InBody is a tool which uses bio electric impedance to measure the body composition. This study will compare both approaches. Validation is necessary as it is clinically quite pertinent to accurately assess a patients' body fat percentage, fat free mass, and total body water and changes that are occurring with nutritional support.

Detailed description

This study will use a stratified design. Eligible participants will be categorized with BMI category to receive InBody followed by iDXA. A total of 176 participants will be placed in 1 of 4 arms (n = 44 per arm) based on their BMI: 1) 18.5-24.9; 2) 25-29.9; 3) 30-34.9; and 4) ≥ 35. Within these arms, the 44 participants will participate in an InBody 770® body composition measure as well as an iDXA body composition measure.

Interventions

None listed

Sponsors

BioSpace, Inc.
CollaboratorINDUSTRY
Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Between 18 and 65 years of age * Have a Body Mass Index ≥ 18.5 kg/m2

Exclusion criteria

* Are not English speaking * Are younger than 18 years of age * Weigh more than 450 lbs * Taller than 6'6 due to size constraints of the iDXA * Have a pacemaker, defibrillator, artificial lung, artificial heart, electrocardiograph, or nerve simulator * People having radioactive iodine thyroid treatment. * People who have had a nuclear medicine study or a barium X-ray within the last 5 days. * People with large amounts of metal in their bodies. * People with arthritis of the spine recorded in the medical record. * Are pregnant

Design outcomes

Primary

MeasureTime frameDescription
Body Composition Measures1 daycompare body composition measures between InBody and iDXA

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026